1. Describe possible harms and benefits of statin therapy in life limiting illness

2. Understand the results of a randomized controlled trial of discontinuing statin therapy

3. Apply relevant data to shared decision making about statin therapy with patients

Session date: 
11/09/2017 - 8:00am to 9:00am CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Huber, MD